Products for Research Use Only
RegisterLogin

DBCO-PEG-OH (MW 2000)

CAT: 0804-HY-174963CSize: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-174963CSize:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
DBCO-PEG-OH (MW 2000) is a PEG derivative composed of DBCO, PEG, and hydroxyl groups. DBCO-PEG-OH (MW 2000) contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups[1].
UNSPSC
12352200
Target
Biochemical Assay Reagents
Related Pathways
Others
Field of Research
Others
Smiles
O=C(CCCCC(NCCO[H])=O)N(C1)C2=C(C=CC=C2)C#CC3=C1C=CC=C3.[n]
Molecular Weight
2000 (Average)
References & Citations
[1]Koo J, et al. Enhancing glioblastoma therapy via intranasal administration of highly potent cell-penetrating peptide decorated nanoparticles. J Control Release. 2025 Feb 10;378:997-1012.
Shipping Conditions
Room temperature
Scientific Category
Biochemical Assay Reagents
Clinical Information
No Development Reported

Related Products

CatalogName
HY-174935ADBCO-PEG-NHS (MW 2000)
HY-D2847FITC-PEG-DBCO (MW 2000)
HY-D2521Cy3-PEG-DBCO (MW 2000)
HY-D2616ICG PEG DBCO (MW 2000)
HY-174912CDBCO-PEG-LA (MW 2000)
HY-130809BDBCO-PEG-Biotin (MW 2000)
HY-W1123936CDBCO-PEG-FA (MW 2000)
HY-D2548Cy5-PEG-DBCO (MW 2000)
HY-164035-01DOPE-PEG-DBCO (MW 2000)
HY-W440835-01DSPE-PEG-DBCO, MW 2000

Alternative Products

CatalogName
GTR19265515-01DBCO-PEG-OH (MW 2000)
T210655-01ICG PEG DBCO (MW 2000)
T207219-01FITC-PEG-DBCO (MW 2000)
TCL-01854-01DBCO-PEG-NHS (MW 2000)
TCL-01688-01DBCO-PEG-FA (MW 2000)
GTR19340572-01Cy3-PEG-DBCO (MW 2000)
GTR19265795-01DBCO-PEG-SH (MW 2000)
GTR19257233-01DOPE-PEG-DBCO (MW 2000)
T205069-01Cy5-PEG-DBCO (MW 2000)
TCL-01431-01DBCO-PEG-Biotin (MW 2000)

Popular Products